Analysts at StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a report released on Tuesday. The firm set a “sell” rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Price Performance
Aeterna Zentaris stock opened at $3.76 on Tuesday. The stock’s fifty day moving average price is $4.56 and its two-hundred day moving average price is $6.21. Aeterna Zentaris has a one year low of $3.96 and a one year high of $12.00. The firm has a market cap of $6.75 million, a PE ratio of -0.25 and a beta of 1.55.
Aeterna Zentaris Company Profile
Recommended Stories
- Five stocks we like better than Aeterna Zentaris
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Whirlpool’s High Dividend Yield Is Too Good to Pass Up
- 3 Small Caps With Big Return Potential
- Holiday Spending Boom Ahead: 3 BNPL Stocks Poised for Gains
- About the Markup Calculator
- Boeing: A Perfect Storm of Trouble Is a Loaded Buying Opportunity
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.